{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:21:06Z","timestamp":1790050866771,"version":"4.0.1"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Identifying tumor characteristics that correlate with metastasis and survival in patients with conjunctival melanoma can potentially lead to better outcomes through a better selection of patients for adjuvant treatments including potentially life-saving new melanoma therapy. The objective of this study was to validate the conjunctival melanoma staging criteria in the <jats:italic toggle=\"yes\">American Joint Committee on Cancer<\/jats:italic> (<jats:italic toggle=\"yes\">AJCC<\/jats:italic>) <jats:italic toggle=\"yes\">Cancer Staging Manual<\/jats:italic> (<jats:italic toggle=\"yes\">8th edition<\/jats:italic>) and explore the prognostic importance of tumor thickness, histologic ulceration, and sentinel lymph node biopsy (SLNB) findings in patients with conjunctival melanoma. This is a case series of 88 consecutive patients with conjunctival melanoma. Clinicopathologic characteristics were analyzed. Associations between pathologic characteristics and outcomes were studied using Kaplan-Meier survival analysis. Local recurrence, lymph node metastasis, distant metastasis, and disease-specific survival (DSS) were the main outcome measures. The study included 56 women and 32 men; the median age was 62 years. At presentation, 41 patients had T1 disease, 23 had T2 disease, 23 had T3, and 1 had T4 disease. Sixty-six patients had invasive conjunctival melanoma (median thickness, 1.56\u2009mm), 17 had conjunctival melanoma in situ, and in 5 patients, tumor thickness could not be determined. Overall, 22 patients had ulceration. In total, 31 patients underwent SLNB, and 4 had a positive sentinel lymph node (SLN). The median follow-up time was 46.6 months. Overall, 12 patients had nodal metastasis at presentation or during follow-up, 19 patients had distant metastasis at last follow-up, and 14 patients died of the disease. Tumor thickness and ulceration were associated with increased risks of nodal metastasis, distant metastasis, and death from the disease. Overall, greater clinical T category at presentation was associated with increased risks of distant metastasis and disease-related death; however, the risks of distant metastasis and disease-related death did not differ between T1 (bulbar) and T2 (nonbulbar) tumors or between T2c,d (caruncular) and T1-T2a,b (noncaruncular) tumors. In patients who underwent SLNB, a positive SLN was associated with worse distant metastasis free survival and DSS. Consideration should be given to adding ulceration and emphasizing tumor thickness as the main determinants of pathologic T category for conjunctival melanoma in future AJCC classifications. The significant association between a positive SLN and worse DSS highlights the importance of SLNB for prognosis in patients with conjunctival melanoma and selecting high-risk patients for adjuvant drug treatment.<\/jats:p>","DOI":"10.1097\/pas.0000000000001344","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T07:50:37Z","timestamp":1566028237000},"page":"1701-1710","source":"Crossref","is-referenced-by-count":43,"title":["Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma"],"prefix":"10.1097","volume":"43","author":[{"given":"Bita","family":"Esmaeli","sequence":"first","affiliation":[{"name":"Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Rubin","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqiong","family":"Xu","sequence":"additional","affiliation":[{"name":"Orbital Oncology and Ophthalmic Plastic Surgery, Department of Plastic Surgery"},{"name":"Department of Ophthalmology, Ninth People\u2019s Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan P.","family":"Goepfert","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan L.","family":"Curry","sequence":"additional","affiliation":[{"name":"Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor G.","family":"Prieto","sequence":"additional","affiliation":[{"name":"Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ning","sequence":"additional","affiliation":[{"name":"Biostatistics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Tetzlaff","sequence":"additional","affiliation":[{"name":"Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,8,14]]},"reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12253-018-0419-3","article-title":"Conjunctival melanoma\u2014epidemiological trends and features","volume":"24","author":"Kastelan","year":"2018","journal-title":"Pathol Oncol Res"},{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/bjophthalmol-2017-311530","article-title":"Population-based incidence of conjunctival tumors in Olmsted County, Minnesota","volume":"102","author":"Dalvin","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0002-9394(02)02288-2","article-title":"Conjunctival melanoma: is it increasing in the United States?","volume":"135","author":"Yu","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0560.2010.01625.x","article-title":"Conjunctival melanoma: local-regional control rates, and impact of high-risk histologic features","volume":"38","author":"Savar","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/IOP.0b013e3182611670","article-title":"American Joint Committee on Cancer (AJCC) clinical classification predicts conjunctival melanoma outcomes","volume":"28","author":"Shields","year":"2012","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.survophthal.2016.06.001","article-title":"Advances in the management of conjunctival melanoma","volume":"62","author":"Vora","year":"2017","journal-title":"Surv Ophthalmol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1136\/bjophthalmol-2017-311082","article-title":"Treatment of conjunctival melanoma in a Dutch referral center","volume":"102","author":"Brouwer","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archophthalmol.2011.2566","article-title":"Predictive value of the seventh edition American Joint Committee on Cancer staging system for conjunctival melanoma","volume":"130","author":"Yousef","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/bjo.78.4.252","article-title":"Prognostic factors in a primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases","volume":"78","author":"Paridaens","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1001\/jamaophthalmol.2017.4837","article-title":"Molecular characteristics of conjunctival melanoma using whole-exome sequencing","volume":"135","author":"Swaminathan","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaophthalmol.2015.3200","article-title":"A retrospective review of conjunctival melanoma presentation, treatment, and outcome and an investigation of features associated with BRAF mutations","volume":"133","author":"Larsen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"R13-20230922","first-page":"3399","article-title":"Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites","volume":"43","author":"Tuomaala","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20230922","first-page":"64","article-title":"Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis)","volume":"110","author":"Esmaeli","year":"2012","journal-title":"Trans Am Ophthalmol Soc"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1136\/bjophthalmol-2014-305730","article-title":"Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients","volume":"99","author":"Sheng","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00002341-200111000-00010","article-title":"Sentinel lymph node biopsy for conjunctival melanoma","volume":"17","author":"Esmaeli","year":"2001","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1001\/archopht.121.12.1779","article-title":"Conjunctival melanoma with a positive sentinel lymph node","volume":"121","author":"Esmaeli","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.ophtha.2009.04.012","article-title":"Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients","volume":"116","author":"Savar","year":"2009","journal-title":"Ophthalmology"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1111\/aos.13252","article-title":"Sentinel lymph node biopsy for ocular adnexal melanoma","volume":"95","author":"Pfeiffer","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1136\/bjophthalmol-2013-303671","article-title":"Prospective study of sentinel lymph node biopsy for conjunctival melanoma","volume":"97","author":"Cohen","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/IOP.0b013e31827472c5","article-title":"Sentinel lymph node biopsy for eyelid and conjunctival tumors: what have we learned in the past decade?","volume":"29","author":"Pfeiffer","year":"2013","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1001\/jamaophthalmol.2018.3488","article-title":"Immunotherapy with programmed cell death 1 inhibitors for 5 patients with conjunctival melanoma","volume":"136","author":"Sagiv","year":"2018","journal-title":"JAMA Ophthalmol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:51:43Z","timestamp":1695423103000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001344"}},"subtitle":["Implications for Future AJCC Classifications"],"short-title":[],"issued":{"date-parts":[[2019,8,14]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001344","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,14]]}}}